Page: 1 | 2 | 3 | 4 | 5
0%
| Resume a previously saved form
Resume Later

In order to be able to resume this form later, please enter your email and choose a password.

Password must contain the following:
  • 12 Characters
  • 1 Uppercase letter
  • 1 Lowercase letter
  • 1 Number
  • 1 Special character
Prostate Cancer Foundation of Australia Logo

Prostate Cancer Foundation of Australia Review of the DRAFT 2025 Clinical Guidelines for the Early Detection of Prostate Cancer

Public Comment Period

Thank you for your interest in contributing to the public consultation for the development of the DRAFT 2025 Clinical Guidelines for the Early Detection of Prostate Cancer.

Your feedback is confidential. Any identifying and personal information will not be disclosed or released to a third party. Your de-identified feedback will only be published with your consent.

If you have any concerns regarding the conduct of this process, please contact the Project Team on research@pcfa.org.au  
 
The deadline for comments is midnight on Sunday 25 May, 2025.

To view information about the public consultation process, and what type of feedback will be considered, consultation material and helpful information visit pcfa.org.au/public-consultation/
Privacy Information

Any personal information collected via this website will be stored and used in accordance with PCFA’s obligations under the Privacy Act 1988, and in accordance with the PCFA Privacy Policy. All information collected will be de-identified for reporting purposes.


* indicates a required field

Personal / organisational information








Please select all that apply.

(check all that apply)
If you are a national organisation, please tick (National Organisation)






* indicates a required field

Click here more information on the NHMRC Identifying and Managing Conflicts of Interest Guidelines

Feedback on Guideline Sections

The DRAFT 2025 Guidelines are set out in multiple sections:
- Introduction
- Executive Summary
- Section A: Risk assessment
- Section B: Decision support
- Section C: Priority populations
- Section D: Early detection
- Section E: Management
- Section F: Guideline implementation and monitoring
- Section G: Emerging evidence and future research priorities
- Appendices
- References
- Resources and useful links

We invite feedback on any section of the DRAFT 2025 Guidelines. Below, there are questions that seek feedback on specific aspects of the DRAFT 2025 Guidelines. 

You do not have to provide feedback on all sections or respond to all questions. Please focus on the topics of most interest to you and/or your organisation.

Where possible, please refer to the relevant section and page number of the DRAFT 2025 Guidelines when providing comments. 













Select all areas you would like to feedback on.




























Submit

The submissions are reported back to the National Health and Medical Research Council (NHMRC). This is a requirement of the NHMRC guideline development reporting process.

Upon completion, all submissions and responses will be anonymised and made available in a Public Consultation Report published on the PCFA website. If you select no, your submission will remain anonymous as part of the NHMRC reporting process and will be redacted in the Public Consultation Report that will be made available.

Your name and email address will not be published.

Save my progress and resume later | Resume a previously saved form